Compare · AZZ vs STE
AZZ vs STE
Side-by-side comparison of AZZ Inc. (AZZ) and STERIS plc (Ireland) (STE): market cap, price performance, sector, and recent activity on the wire.
Summary
- AZZ operates in Industrials, while STE operates in Health Care - the two are in different parts of the market.
- STE is the larger of the two at $21.26B, about 4.8x AZZ ($4.42B).
- Over the past year, AZZ is up 31.8% and STE is down 3.4% - AZZ leads by 35.2 points.
- AZZ has been more active in the news (17 items in the past 4 weeks vs 1 for STE).
- STE has more recent analyst coverage (16 ratings vs 14 for AZZ).
- Company
- AZZ Inc.
- STERIS plc (Ireland)
- Price
- $147.10-2.59%
- $217.88-1.46%
- Market cap
- $4.42B
- $21.26B
- 1M return
- -4.08%
- +5.46%
- 1Y return
- +31.83%
- -3.39%
- Industry
- Industrial Specialties
- Industrial Specialties
- Exchange
- NYSE
- NYSE
- IPO
- News (4w)
- 17
- 1
- Recent ratings
- 14
- 16
AZZ Inc.
AZZ Inc. provides galvanizing and metal coating solutions, welding solutions, specialty electrical equipment, and engineered services to the power generation, transmission, distribution, refining, and industrial markets in the United States and internationally. The company operates through two segments, Infrastructure Solutions and Metal Coatings. The Metal Coatings segment offers hot dip galvanizing, powder coating, anodizing, plating, and other metal coating applications to the steel fabrication and other industries. It serves fabricators or manufacturers that provide services to the electrical and telecommunications, bridge and highway, petrochemical, and general industrial markets, as well as original equipment manufacturers. The Infrastructure Solutions segment provides products and services to support industrial and electrical applications. It offers custom switchgear, electrical enclosures, medium and high voltage bus ducts, explosion proof and hazardous duty lighting, nuclear safety-related equipment, and tubular products, as well as solutions and engineering resources to multi-national companies and small independent companies. This segment sells its products through internal sales force, manufacturers' representatives, distributors, and agents. The company was incorporated in 1956 and is headquartered in Fort Worth, Texas.
STERIS plc (Ireland)
STERIS plc provides infection prevention and other procedural products and services worldwide. It operates in three segments: Healthcare, Applied Sterilization Technologies, and Life Sciences. The Healthcare segment offers cleaning chemistries and sterility assurance products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. This segment offers its products and services to acute care hospitals and other healthcare settings. The Applied Sterilization Technologies segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of approximately 50 contract sterilization and laboratory facilities. The Life Sciences segment designs, manufactures and sells consumable products, such as formulated cleaning chemistries, barrier and sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. The company is based in Dublin, Ireland.
Latest AZZ
- AZZ Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- SEC Form 10-Q filed by AZZ Inc.
- AZZ Inc. Reports Fiscal Year 2027 First Quarter Results
- Director Berce Daniel E was granted 937 shares, increasing direct ownership by 2% to 59,290 units (SEC Form 4)
- Director Mcgough Ed was granted 937 shares, increasing direct ownership by 5% to 20,306 units (SEC Form 4)
- Director Grannum Clive A was granted 937 shares, increasing direct ownership by 9% to 11,145 units (SEC Form 4)
- Director Purvis Steven R. was granted 937 shares, increasing direct ownership by 4% to 23,862 units (SEC Form 4)
- Director Schapper Aaron M was granted 937 shares (SEC Form 4)
- Director Treadway Charles L. was granted 937 shares (SEC Form 4)
- Director Jackson Carol R was granted 937 shares, increasing direct ownership by 9% to 11,145 units (SEC Form 4)
Latest STE
- Director Sohi Mohsen exercised 3,781 units of Ordinary Shares at a strike of $71.40 and covered exercise/tax liability with 1,837 units of Ordinary Shares, increasing direct ownership by 9% to 24,305 units (SEC Form 4)
- SEC Form 11-K filed by STERIS plc (Ireland)
- Sr. VP, Gen Counsel, and Sec. Zangerle John Adam sold $296,968 worth of Ordinary Shares (1,419 units at $209.28), decreasing direct ownership by 4% to 35,259 units (SEC Form 4)
- SEC Form 144 filed by STERIS plc (Ireland)
- Sr. VP, Gen Counsel, and Sec. Zangerle John Adam covered exercise/tax liability with 401 units of Ordinary Shares, decreasing direct ownership by 1% to 36,678 units (SEC Form 4)
- V.P. & Corporate Treasurer Tamaro Renato covered exercise/tax liability with 65 units of Ordinary Shares, decreasing direct ownership by 1% to 6,194 units (SEC Form 4)
- Sr. VP and GM, Life Sciences Madsen Julia covered exercise/tax liability with 195 units of Ordinary Shares, decreasing direct ownership by 2% to 12,257 units (SEC Form 4)
- SVP & GM, AST Kohler Kenneth E covered exercise/tax liability with 150 units of Ordinary Shares, decreasing direct ownership by 1% to 11,332 units (SEC Form 4)
- SVP & Chief HRO Fraser Mary Clare covered exercise/tax liability with 600 units of Ordinary Shares, decreasing direct ownership by 4% to 13,716 units (SEC Form 4)
- President and CEO Carestio Daniel A covered exercise/tax liability with 1,889 units of Ordinary Shares and sold $946,799 worth of Ordinary Shares (4,428 units at $213.82), decreasing direct ownership by 9% to 63,647 units (SEC Form 4)